|
Home
|
E-Submission
|
Sitemap
|
Contact Us
|
HOME
ABOUT
Aims and Scope
About the Journal
Editorial Board
Management Team
Open Access
Best Practice
Subscription Information
Contact us
BROWSE ARTICLES
All issues
Current Issue
Accepted Manuscripts
Most Read Articles
Most Cited Articles
KJCO Search
Author Index
EDITORIAL POLICIES
Research and Publication Ethics
Advertising Policy
Data Sharing Policy
Archiving Policy
Crossmark Policy
FOR CONTRIBUTORS
Instructions for Authors
Checklist
Copyright Transfer Agreement
Article-processing charge
Conflict of Interest Form
E-Submission
KJCO Search
> BROWSE ARTICLES > KJCO Search
Exploring the clinicopathological parameters of HER2 low breast cancers: insights from a retrospective cohort study
Sana Ahuja, Adil Aziz Khan, Kiruthikasri G, Sufian Zaheer
Korean J Clin Oncol.
2024;20(2):79-83. Published online December 31, 2024 DOI:
https://doi.org/10.14216/kjco.24011
Comparison of survival outcomes according of patients with metastatic gastric cancer receiving
trastuzumab
with systemic chemotherapy
Gi-Young Ha, Sung-Hyun Yang, Hye-Jin Kang, Hyo-Lak Lee, Jin Kim, Yun-Ju Kim, Hang-Jong Yu, Jong-Inn Lee, Sung-Ho Jin
Korean J Clin Oncol.
2020;16(2):63-70. Published online December 31, 2020 DOI:
https://doi.org/10.14216/kjco.20011
Cited By 4
Nine months versus 12 months of adjuvant
trastuzumab
for patients with HER2-positive breast cancer
Ashraf Mahmoud El-Enbaby, Nadia Ahmed Abd El Moneim, Gehan Abd El atti Khedr, Yasmine Mohamed Nagy Elwany
Korean J Clin Oncol.
2018;14(2):108-115. Published online December 31, 2018 DOI:
https://doi.org/10.14216/kjco.18019
Cited By 1
1
|
> BROWSE ARTICLES > KJCO Search
